B-cell Acute Lymphoblastic Leukemia (B-ALL) research hub

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

This study is testing a new medicine called AZD0486 for people with a type of blood cancer called B-cell Acute Lymphoblastic Leukaemia (B-ALL). It aims to find out if it's safe, what dose works best, and if it can help fight the cancer when other treatments haven't worked.